2020 annual financial data
Allogene Therapeutics 2020 Operating margin
Direct answer
Operating margin was -673.47%.
Operating income was -258,243,000 USD and net income was -233,471,000 USD.
Operating cash flow was -115,093,000 USD.
Get free Allogene Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 38,345,000 USD
- Operating income
- -258,243,000 USD
- Net income
- -233,471,000 USD
- Operating cash flow
- -115,093,000 USD